Why THBD?

By | About THBD, All | No Comments

As you may know, big things are happening to Texas’ biotechnology industry. What you may not know is that Temple is one of the fastest-growing cities in Texas due to the increasing presence of medical companies, hospitals and industry influence in the area.

The growth of the biotech industry in our area forged legislation by the Texas legislature to create the Temple Health and Bioscience District (THBD), our nonprofit bioscience office and laboratory facility supported by taxpayers and the city. The legislation was created to support the economic development of the biotech industry in Texas. Our goal is to recruit top startups from around the world to grow their companies here in our state.

Located in the middle of Texas, only a couple of hours from Austin, Dallas, Houston and San Antonio, Temple is at the center of Texas’ growing biotech corridor. THBD is the only publicly funded, not-for-profit district in the state of Texas that caters to bioscience, biotech and health-related startup companies. Our mission is to grow 21st century jobs by fostering bioscience education, research, and healthcare in central Texas.

At THBD, we provide our tenants with everything they need to take their ideas from conception t o commercialization. Our 5,000-sq. ft. laboratory and office facility provides tenants with equipment for prototyping, testing, 3D printing and tissue culture. In addition to office and laboratory space, THBD provides resources, funding opportunities, mentorship and networking opportunities with local area collaborators including Baylor Scott and White hospital system, USDA, Agrilife Research Center, Texas A&M Health Science Center (medical school) and the fourth largest U.S. Department of Veterans Affairs (VA) in the country.

Tenant Spotlight: SiMMo3D

By | About THBD, Startups, Tenants | No Comments

This innovative startup company joined the Temple Health and Bioscience District (THBD) facility at the beginning of 2017 and has reached many major milestones during its time in our incubator.

SiMMo3D is a Texas-based medical company that produces synthetic organ models generated from imaging data to create medical device implantation trainers. Their hands-on surgical skills trainer, SimuBoard, improves the proficiency, outcome, and adoption rate for medical devices. SiMMo3D is focused on resolving improper medical device implantation and alleviating difficulties that medical device companies face in gaining a larger adoption rate for their devices. SimuBoard Medical Device Implantation Trainers currently include the Transseptal Puncture Trainer and the Left Atrial Appendage (LAA) Occlusion Trainer.

While current training solutions are cost prohibitive, time intensive, wasteful and lack quantifiable data, SiMMo3D’s products offer an interactive learning experience with anatomical accuracy and valuable training data. The SiMMo3D team includes Co-Founder and CEO Ryan Quinn and Co-Founder and CTO Colin Dodson.

Ryan graduated from UTSA with a Bachelor of Science in Entrepreneurship. After graduation, he won the San Antonio Center for Innovative Technology Entrepreneurship (CITE) competition for his company, V.I. Solutions. Through CITE, Ryan discovered a passion for working in the biomedical industry and 3D printing. Soon afterward in 2016, he founded SiMMo3D.

Colin is involved in the strategic development of the company’s core technology. He graduated from Texas A&M University as a Research Scholar with a Bachelor of Science in Biomedical Engineering. Colin joined SiMMo3D to pursue his entrepreneurial interests and uses his knowledge of medical devices to create better training models for the medical community.

In addition to their cutting-edge technology, this dynamic duo brings life and excitement into THBD. We can always count on Ryan and Colin for a good laugh or story. Each tenant at THBD brings a unique personality into the working environment, which is what makes our facility such a great place to create and collaborate.

Learn more about SiMMo3D’s technology at www.simmo3d.com.

Bioscience District to livestream learning series

By | Business Resources, News, Press Coverage | No Comments

August 24, 2018
Temple Daily Telegram|By Janice Gibbs

The Temple Health and Bioscience District will be one of two sites to livestream the Texas Health CoLab’s monthly learning series from Dell Medical School.

The series will be 1-3 p.m. Thursday, Aug. 30.

John Paulos will be presenting “What Angels Look For: Investing in Health Care Entrepreneurship.”

Early funding often comes from angel investment groups. Paulo will talk about the Central Texas Angel Network interest in health care innovation, what drives angels, what the group is looking for, the benefits to your company and how you can best prepare yourself for an application.

The Temple High interns at the Bioscience District started in mid August. Briana Miles and Eric Brown, both seniors, will work 15 hours per week for 36 weeks.

George Robinson, Texas Bioscience Institute intern, spent the summer working with SiMMo3D, a District tenant. Ryan Quinn and Colin Dodson, SiMMo3D cofounders, asked Robinson to continue to work for them during the school year.

The Bioscience District facility has five tenants and has two offices and one lab available.

Neurofront Technologists is renewing its lease for an office. Neurosurgeon Dr. Jason Huang is releasing his lab, opening it up for another tenant.

Eclipse Diagnostics, a company in Israel, is interested in becoming a tenant, according to Tami Annable, executive director of the Temple Health and Bioscience District.

Eclipse is developing technology that can be used at home to monitor the risk of stroke.

Dr. Luka Fajs will be visiting in September and Dr. Robert Marks has sent Annable a list of lab equipment they will need.

“The majority of the items on the list are available in the district’s common lab,” she said.

Embryotics, a tenant of an accelerator at Texas Tech University, was recommended to the district by the Texas Tech University Office of Research commercialization.

The company strives to increase pregnancy rates though improved embryo selection technologies in livestock.

Dr. Cara Wessels and Robert Rangel of Embryotics will be visiting Temple in September.

Annable gave a presentation to the National Science Department at the University of Mary Hardin-Baylor.

“I brought Ryan from SiMMo3D and he talked about what he could potentially do for anatomy and physiology classes,” she said. “There was a lot of positive enthusiasm.”

The next board meeting will be in October.